WHITE PAPER
Private Market Opportunity for CAR T-cell Therapy in Asia Pacific
Jan 16, 2024
Download

IQVIA explore the opportunity of private CAR-T delivery across the Asia Pacific region. Our experts assess this opportunity in the context of highly varied public funding arrangements and level of preparedness for CAR-T adoption across APAC countries. This report focuses on three case study markets including Australia as an "Innovative" market, Singapore as an "Advancing" market, and South-East Asia (ex-Singapore) as "Initialising" markets.

Contact Us